Installation
About
Phase I/II adaptive dose-finding design for combination studies where toxicity rates are supposed to increase with both agents.
Key Metrics
Downloads
Yesterday | 40 0% |
Last 7 days | 98 -26% |
Last 30 days | 557 +50% |
Last 90 days | 1.216 +15% |
Last 365 days | 4.523 +2% |
Maintainer
Maintainer | Jacques-Henri Jourdan |